Pneumococcal Vaccines Market

Pneumococcal Vaccines Market: North America to Register Fastest Growth During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Ask The Analyst Customization Available Request Methodology

Pneumococcal disease is an infection caused by streptococcus pneumonia. Pneumococcal infection can result in pneumonia, bacteremic pneumonia, bacteremia, meningitis, bloodstream infection and middle ear infection. There are two main types of pneumococcal diseases, namely non-invasive and invasive pneumococcal diseases. Invasive pneumococcal diseases, such as bacteremia (sepsis), meningitis and bacteremic pneumonia, tend to be more serious compared to non-invasive. Serotypes 1, 4, 5, 7F, 8, 12F, 14, 18C, and 19A are more likely to cause invasive pneumococcal diseases.

According to the World Health Organization, pneumonia accounted for 16% deaths of children aged under 5 year in 2015. Pneumococcal vaccines are used against streptococcus pneumonia. There are 2 types of pneumococcal vaccines available—conjugate vaccines and polysaccharide vaccines. The WHO has recommended pneumococcal conjugate vaccines in the routine immunization for children. In this report, the pneumococcal vaccines market is further categorized into product type and distribution channel. The report provides market size and forecast for pneumococcal vaccines against streptococcus pneumonia, inclusive of both types of vaccines. The report analyses the demand for pneumococcal vaccines form pharmacies, public health agencies, community clinics and other distribution channels.

Market Value and Forecast

In terms of revenue, the global pneumococcal vaccines market is projected to expand at 9.1% CAGR over the forecast period of 2018–2028. The pneumococcal vaccines market is expected to be valued at US$ 18,456.5 Mn by 2028 end. The addition of pneumococcal vaccine national immunization programs and development of new pneumococcal vaccines are expected to boost the growth of the global pneumococcal vaccines market over the forecast period. According to the World Health Organization, pneumococcal vaccines were added in the national immunization programs of 138 countries till 2017.

Market Dynamics

The global demand for pneumococcal vaccines is growing as a result of increasing initiatives by government and private organizations to provide vaccination in developing countries. Public–private partnerships to provide low-cost pneumococcal vaccines in middle-income countries is also expected to propel the growth of the pneumococcal vaccines market. Pneumococcal vaccines are introduced in more than 57 Gavi-supported countries under the advance market commitment. Development of pneumococcal vaccines for all age groups is expected to create favourable growth opportunities for the pneumococcal vaccines market. Likewise, increasing awareness among parents regarding vaccination, catch up champignons to reduce IPD risk and partnerships & funding for development of new vaccines are expected to boost the growth of the global pneumococcal vaccines market. However, low immunization coverage for new pneumococcal vaccines, slow introduction of vaccines in middle-income countries, low awareness among older population regarding pneumococcal vaccination are some of the factors expected to hamper the growth of the pneumococcal vaccines market.

Key Regions

Geographically, the global pneumococcal vaccines market is segmented into seven major regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (Asia-Pacific excluding Japan), Japan and the Middle East & Africa (MEA). In terms of value, North America was the dominant regional market for pneumococcal vaccines in 2017 and is expected to expand at high CAGR of 10.2% over the forecast period of 2018–2028.  Asia Pacific is expected to contribute significant revenue share in the global pneumococcal vaccine market due to increasing government funding and the addition of pneumococcal vaccines in national immunization programs in the region.

Pneumococcal-Vaccines-Market.jpg

Key Players

Examples of some of the key players identified in the global pneumococcal vaccines market are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., and Merck & Co., Inc., among others. Manufacturers are focusing on research and development activities to develop multivalent pneumococcal vaccines. Pfizer Inc. and GlaxoSmithKline Plc. have collaborated with Gavi vaccine alliance to supply their pneumococcal vaccines in Gavi-supported countries. Through this collaboration, both the companies have increased their presence in the market and contribute to the immunization program.

Future Market Insights (FMI) offers a 10-year forecast on the global pneumococcal vaccines market. The primary objective of the report is to offer updates and information related to opportunities in the global pneumococcal vaccines market.

Report Description

In terms of revenue, the global pneumococcal vaccines market is expected to register a CAGR of 9.1% during the forecast period of 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global pneumococcal vaccines market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global pneumococcal vaccines market are presented in the report.

The global demand for pneumococcal vaccines is increasing as a result of the large burden of pneumonia-related child mortality rate. Pneumonia is the leading cause of child deaths. 16% of all deaths under age 5 are due to pneumonia. The governments across the globe are focusing on reducing the mortality rate with the help of pneumococcal immunization, which is expected to fuel the growth of the pneumococcal vaccines market. Besides, the support from Gavi to low-income countries for pneumococcal immunization is expected to boost the growth of the pneumococcal vaccines market. Availability of cost-effective vaccines in developing countries as well as favourable reimbursement policies for pneumococcal conjugate and polysaccharide vaccine are expected to spur the demand for pneumococcal vaccines.

Research & development activities for the development of new pneumococcal vaccines, balanced supply and demand, government and private funding for pneumococcal vaccines are expected to boost the demand for pneumococcal vaccines over the forecast period. Manufacturers are focusing on mergers and collaborations for the development of new vaccines, whereas increasing pharmacy-based pneumococcal immunization is expected to create huge opportunities for growth of the pneumococcal vaccines market.

The revenue of the pneumococcal vaccines market in North America is expected to grow at the high rate. To understand and assess opportunities in this market, the report offers the market forecast on the basis of product type and distribution channel. The report provides analysis of the global pneumococcal vaccines market in terms of market value (US$ Mn).

The report begins with the market definition, followed by definitions of the different pneumococcal vaccines types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global pneumococcal vaccines market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights

The subsequent section of the report provides analysis of the market on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:

  • North America

    • U.S.

    • Canada

  • Latin America

    • Brazil

    • Mexico

    • Rest of Latin America

  • Western Europe

    • Germany

    • Italy

    • France

    • Spain

    • U.K.

    • Rest of Western Europe

  • Eastern Europe

    • Russia

    • Poland

    • Rest of Eastern Europe

  • Asia Pacific Excluding Japan

    • India

    • China

    • ASEAN

    • Australia & New Zealand

    • Rest of APEJ

  • Japan

  • Middle East & Africa (MEA)

    • GCC Countries

    • South Africa

    • Rest of MEA

The next section provides competitive edge of the global pneumococcal vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the pneumococcal vaccines market. The competition landscape section provides dashboard view of the activities of major players in the global pneumococcal vaccines market. The company profiles section provides information on the key offerings of each player in the global pneumococcal vaccines market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis. The key players included in this report are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co., Inc.

The next section analyses the market on the basis of product type and presents the forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:

  • Pneumococcal Polysaccharide Vaccines

  • Pneumococcal Conjugate Vaccines

The next section analyses the market on the basis of the distribution channel and presents forecast in terms of value (US$ Mn) for the next 10 years. The distribution channels covered in the report include:

  • Pharmacies

  • Community Clinics

  • Public Health Agencies

  • Others

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global pneumococcal vaccines market.

Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by pneumococcal vaccines market. To understand the key segments in terms of their growth and performance in the global pneumococcal vaccines market, Future Market Insights has developed a market attractiveness index. The resulting index will help providers to identify the existing market opportunities.

Pneumococcal Vaccines Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Pneumococcal Vaccines Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Key Trends

5. Key Inclusions

5.1. Disease Epidemiology

5.2. Reimbursement Scenario

5.3. Pipeline Assessment

6. Respiratory Syncytial Virus (RSV) Vaccines Market, Pipeline Assessment

7. North America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017

7.2.1. U.S.

7.2.2. Canada

7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

7.4.1. Pneumococcal Conjugate Vaccines

7.4.2. Pneumococcal Polysaccharide Vaccines

7.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

7.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

7.6.1. Pharmacies

7.6.2. Community Clinics

7.6.3. Public Health Agencies

7.6.4. Others

7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

7.8. Market Attractiveness Analysis

7.8.1. By Country

7.8.2. By Product

7.8.3. By Distribution Channel

7.9. Key Market Participants – Intensity Mapping

8. Latin America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

8.1. Introduction

8.2. Historical Market Size (US$ Mn) By Country, 2013–2017

8.2.1. Brazil

8.2.2. Mexico

8.2.3. Rest of Latin America

8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

8.4.1. Pneumococcal Conjugate Vaccines

8.4.2. Pneumococcal Polysaccharide Vaccines

8.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

8.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

8.6.1. Pharmacies

8.6.2. Community Clinics

8.6.3. Public Health Agencies

8.6.4. Others

8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

8.8. Market Attractiveness Analysis

8.8.1. By Country

8.8.2. By Product

8.8.3. By Distribution Channel

8.9. Key Market Participants – Intensity Mapping

9. Western Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

9.1. Introduction

9.2. Historical Market Size (US$ Mn) By Country, 2013–2017

9.2.1. Germany

9.2.2. France

9.2.3. U.K.

9.2.4. Spain

9.2.5. Italy

9.2.6. Rest of Western Europe

9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

9.4.1. Pneumococcal Conjugate Vaccines

9.4.2. Pneumococcal Polysaccharide Vaccines

9.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

9.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

9.6.1. Pharmacies

9.6.2. Community Clinics

9.6.3. Public Health Agencies

9.6.4. Others

9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

9.8. Market Attractiveness Analysis

9.8.1. By Country

9.8.2. By Product

9.8.3. By Distribution Channel

9.9. Key Market Participants – Intensity Mapping

10. Eastern Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

10.1. Introduction

10.2. Historical Market Size (US$ Mn) By Country, 2013–2017

10.2.1. Russia

10.2.2. Poland

10.2.3. Rest of Eastern Europe

10.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

10.4.1. Pneumococcal Conjugate Vaccines

10.4.2. Pneumococcal Polysaccharide Vaccines

10.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

10.6.1. Pharmacies

10.6.2. Community Clinics

10.6.3. Public Health Agencies

10.6.4. Others

10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

10.8. Market Attractiveness Analysis

10.8.1. By Country

10.8.2. By Product

10.8.3. By Distribution Channel

10.9. Key Market Participants – Intensity Mapping

11. Asia Pacific excluding Japan and China (APEJ) Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

11.1. Introduction

11.2. Historical Market Size (US$ Mn) By Country, 2013–2017

11.2.1. India

11.2.2. China

11.2.3. Australia and New Zealand

11.2.4. ASEAN

11.2.5. Rest of APEJ

11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

11.4.1. Pneumococcal Conjugate Vaccines

11.4.2. Pneumococcal Polysaccharide Vaccines

11.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

11.6.1. Pharmacies

11.6.2. Community Clinics

11.6.3. Public Health Agencies

11.6.4. Others

11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

11.8. Market Attractiveness Analysis

11.8.1. By Country

11.8.2. By Product

11.8.3. By Distribution Channel

11.9. Key Market Participants – Intensity Mapping

12. Japan Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

12.2.1. Pneumococcal Conjugate Vaccines

12.2.2. Pneumococcal Polysaccharide Vaccines

12.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

12.4. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

12.4.1. Pharmacies

12.4.2. Community Clinics

12.4.3. Public Health Agencies

12.4.4. Others

12.5. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

12.6. Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Distribution Channel

12.7. Key Market Participants – Intensity Mapping

13. MEA Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

13.1. Introduction

13.2. Market Size (US$ Mn) Forecast By Country, 2018–2028

13.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

13.3.1. Pneumococcal Conjugate Vaccines

13.3.2. Pneumococcal Polysaccharide Vaccines

13.4. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

13.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

13.5.1. Pharmacies

13.5.2. Community Clinics

13.5.3. Public Health Agencies

13.5.4. Others

13.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

13.7. Market Attractiveness Analysis

13.7.1. By Country

13.7.2. By Product

13.7.3. By Distribution Channel

13.8. Key Market Participants – Intensity Mapping

14. Forecast Factors: Relevance and Impact

15. Drivers and Restraints: Impact Analysis

16. Macroeconomic Assumptions

17. Market Share Analysis

18. Competition Analysis

18.1. Competition Dashboard

18.2. Company Deep Dive

18.2.1. Pfizer Inc.

18.2.1.1. Overview

18.2.1.2. Product Portfolio

18.2.1.3. Production Footprint

18.2.1.4. Sales Footprint

18.2.1.5. Strategy

18.2.1.5.1. Marketing Strategy

18.2.1.5.2. Product Strategy

18.2.1.5.3. Channel Strategy

18.2.2. Merck & Co., Inc.

18.2.2.1. Overview

18.2.2.2. Product Portfolio

18.2.2.3. Production Footprint

18.2.2.4. Sales Footprint

18.2.2.5. Strategy

18.2.2.5.1. Marketing Strategy

18.2.2.5.2. Product Strategy

18.2.2.5.3. Channel Strategy

18.2.3. GlaxoSmithKline plc.

18.2.3.1. Overview

18.2.3.2. Product Portfolio

18.2.3.3. Production Footprint

18.2.3.4. Sales Footprint

18.2.3.5. Strategy

18.2.3.5.1. Marketing Strategy

18.2.3.5.2. Product Strategy

18.2.3.5.3. Channel Strategy

18.2.4. Sanofi SA

18.2.4.1. Overview

18.2.4.2. Product Portfolio

18.2.4.3. Production Footprint

18.2.4.4. Sales Footprint

18.2.4.5. Strategy

18.2.4.5.1. Marketing Strategy

18.2.4.5.2. Product Strategy

18.2.4.5.3. Channel Strategy

19. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Region

19.1. Introduction / Key Findings

19.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017

19.2.1. North America

19.2.2. Western Europe

19.2.3. Eastern Europe

19.2.4. Latin America

19.2.5. Asia Pacific excluding Japan

19.2.6. Japan

19.2.7. Middle East and Africa

19.3. Market Size (US$ Mn) Forecast By Region, 2018–2028

19.4. Market Attractiveness Analysis By Region

20. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Product

20.1. Introduction

20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

20.2.1. Pneumococcal Conjugate Vaccines

20.2.2. Pneumococcal Polysaccharide Vaccines

20.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

20.4. Market Attractiveness Analysis By Product Type

21. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

21.1. Introduction

21.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

21.2.1. Pharmacies

21.2.2. Community Clinics

21.2.3. Public Health Agencies

21.2.4. Others

21.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

21.4. Market Attractiveness Analysis By Distribution Channel

22. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

22.1. Market Value Share Analysis

22.1.1. By Country

22.1.2. By Product

22.1.3. By Distribution Channel

22.2. Y-o-Y Growth Analysis

22.2.1. By Country

22.2.2. By Product

22.2.3. By Distribution Channel

22.3. Absolute $ Opportunity

23. Assumptions and Acronyms

24. Research Methodology

Pneumococcal Vaccines Market Reports - List of Tables

Table 1a: Factors Considered While Setting Vaccine Prices, By Company

Table 1b: Factors Considered While Setting Vaccine Prices, By Company

Table 02a: Pneumococcal Vaccines Market Pipeline Analysis (2017)

Table 02b: Pneumococcal Vaccines Market Pipeline Analysis (2017)

Table 02c: Pneumococcal Vaccines Market Pipeline Analysis (2017)

Table 02d: Pneumococcal Vaccines Market Pipeline Analysis (2017)

Table 03a: RSV Vaccines Market Pipeline Analysis (2017)

Table 03b: RSV Vaccines Market Pipeline Analysis (2017)

Table 03c: RSV Vaccines Market Pipeline Analysis (2017)

Table 03d: RSV Vaccines Market Pipeline Analysis (2017)

Table 03e: RSV Vaccines Market Pipeline Analysis (2017)

Table 03f: RSV Vaccines Market Pipeline Analysis (2017)

Table 04: North America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country

Table 05: North America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 06: North America Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 07: Latin America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country

Table 08: Latin America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 09: Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 10: Western Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country

Table 11: Western Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 12: Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 13: Eastern Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country

Table 14: Eastern Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 15: Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 16: APEJ Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country

Table 17: APEJ Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 18: APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 19: Japan Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 20: Japan Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 21: MEA Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country

Table 22: MEA Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 23: MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel 

Table 24: Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast By Region, 2013–2028

Table 25: Global Pneumococcal Vaccines Market size Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type

Table 26: Global Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel

Pneumococcal Vaccines Market Reports - List of Figures

Figure 01: Market Size (US$ Mn) by Region (2017A & 2028F)

Figure 02: Global Pneumococcal Vaccines Market Value Share By Product Type 2017 (A)

Figure 03: Global Pneumococcal Vaccines Market Value Share By Product Type 2017 (A)

Figure 04: Tiered-price Policies Among Vaccine Manufacturers

Figure 05: Pneumococcal Vaccine Procured Volumes 2010-2017 (in millions of doses) 

Figure 06: Countries Approved for Gavi's Pneumococcal Vaccine Support-

Figure 07: Trends in Invasive Pneumococcal Diseases Among Children Aged <5 year Old, 1998–2016

Figure 08: Summary of AMC Financial Process Flow And Funds Disbursed in Private-public Partnerships (Inception to 31 December 2017) 

Figure 09: Countries With Pneumococcal Conjugate Vaccine in The National Immunization Program and Planned Introductions (In 2018)

Figure 10: Global Coverage of Older Vaccines vs. Newer Vaccines (2016)

Figure 11: Comparison of PCV Uptake in High-income, Gavi-eligible and Gavi-ineligible Countries, 2010–2016 

Figure 12: Number of Children Who Were Unvaccinated, By Country

Figure 13: Distribution of Industry Sponsored Clinical Programs for Pneumococcal Vaccines, by Phase

Figure 14: Distribution of Industry Sponsored Clinical Programs for Pneumococcal Vaccines, by Age Group

Figure 15: Geographical Distribution of Clinical Trials for Pneumococcal Vaccines (2017)

Figure 16: Distribution of Industry Sponsored Clinical Programs for RSV Vaccines, by Phase

Figure 17: Distribution of Industry Sponsored Clinical Programs for RSV Vaccines, by Age Group

Figure 18: Geographical Distribution of Clinical Trials for RSV Vaccines (2017)

Figure 19: North America Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 20: North America Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 21: North America Pneumococcal Vaccines Market Split By Country (2018)

Figure 22: North America Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 23: North America Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 24: U.S. Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 25: U.S. Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 26: Canada Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 27: Canada Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 28: North America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 29: North America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 30: North America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 31: North America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 32: North America Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 33: North America Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 34: North America Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028 

Figure 35: Latin America Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 36: Latin America Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 37: Latin America Pneumococcal Vaccines Market Split By Country (2018)

Figure 38: Latin America Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 39: Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 40: Brazil Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 41: Brazil Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 42: Mexico Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 43: Mexico Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 44: Rest of Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 45: Rest of Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 46: Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 47: Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 48: Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 49: Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 50: Latin America Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 51: Latin America Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 52: Latin America Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028 

Figure 53: Western Europe Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 54: Western Europe Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 55: Western Europe Pneumococcal Vaccines Market Split By Country (2018)

Figure 56: Western Europe Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 57: Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 58: U.K. Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 59: U.K. Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 60: France Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 61: France Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 62: Germany Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 63: Germany Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 64: Italy Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 65: Italy Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 66: Spain Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 67: Spain Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 68: Rest of Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 69: Rest of Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 70: Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 71: Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 72: Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 73: Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 74: Western Europe Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 75: Western Europe Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 76: Western Europe Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028 

Figure 77: Eastern Europe Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 78: Eastern Europe Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 79: Eastern Europe Pneumococcal Vaccines Market Split By Country (2018)

Figure 80: Eastern Europe Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 81: Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 82: Russia Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 83: Russia Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 84: Poland Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 85: Poland Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 86: Rest of Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 87: Rest of Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 88: Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 89: Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 90: Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 91: Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 92: Eastern Europe Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 93: Eastern Europe Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 94: Eastern Europe Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028 

Figure 95: APEJ Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 96: APEJ Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 97: APEJ Pneumococcal Vaccines Market Split By Country (2018)

Figure 98: APEJ Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 99: APEJ Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 100: India Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 101: India Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 102: Australia & New Zealand Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 103: Australia & New Zealand Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 104: China Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 105: China Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 106: ASEAN Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 107: ASEAN Australia & New Zealand Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 108: Rest of APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 109: Rest of APEJ Australia & New Zealand Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 110: APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 111: APEJ Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 112: APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 113: APEJ Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 114: APEJ Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 115: APEJ Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 116: APEJ Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028 

Figure 117: Japan Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 118: Japan Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 119: Japan Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 120: Japan Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 121: Japan Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 122: Japan Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 123: Japan Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 124: Japan Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 125: Japan Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 126: Japan Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 127: MEA Pneumococcal Vaccines Market Split By Product Type (2018)

Figure 128: MEA Pneumococcal Vaccines Market Split By Distribution Channel (2018)

Figure 129: MEA Pneumococcal Vaccines Market Split By Country (2018)

Figure 130: MEA Pneumococcal Vaccines Market Size Analysis, 2013–2017

Figure 131: MEA Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028 

Figure 132: South Africa Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 133: South Africa Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 134: GCC Countries Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 135: GCC Countries Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 136: Rest of MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017

Figure 137: Rest of MEA Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028 

Figure 138: MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines

Figure 139: MEA Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines

Figure 140: MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines

Figure 141: MEA Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines

Figure 142: MEA Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 143: MEA Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028 

Figure 144: MEA Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028 

Figure 145 : Global Pneumococcal Vaccines Market Share Analysis (%) By Region, 2018 & 2028

Figure 146: Global Pneumococcal Vaccines Market Y-o-Y Growth (%) By Region, 2018–2028

Figure 147: Global Pneumococcal Vaccines Market Attractiveness Analysis By Region, 2018–2028 

Figure 148: Global Pneumococcal Vaccines Market Share Analysis (%) By Product Type, 2018 & 2028

Figure 149: Global Pneumococcal Vaccines Market Y-o-Y Growth (%) By Product Type, 2018–2028

Figure 150: Global Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 151: Global Pneumococcal Vaccines Share Analysis (%) By Distribution Channel, 2018 & 2028

Figure 152: Global Pneumococcal Vaccines Market Y-o-Y Growth (%) By Distribution Channel, 2018–2028

Figure 153: Global Pneumococcal Vaccines Market Attractiveness Analysis By distribution channel , 2018–2028 

Figure 154: Global Pneumococcal Vaccines Market Value Analysis and Forecast, 2017–2028 (US$ Mn)

Figure 155: Global Pneumococcal Vaccines Market Absolute $ Opportunity (US$ Mn), 2017–2028